Two-week triple therapy has a higher Helicobacter pylori eradication rate than 1-week therapy: A single-center randomized study

Saudi J Gastroenterol. 2015 Nov-Dec;21(6):355-9. doi: 10.4103/1319-3767.170951.

Abstract

Background and aim: To evaluate a high effective and practical regimen for the eradication of Helicobacter pylori infection.

Patients and methods: The 298 patients with H. pylori infection, diagnosed by biopsies performed during the endoscopy, were randomized into two groups. Group 1: Treated for one week with a combination of omeprazole, amoxicillin, and clarithromycin (OAC), named by OAC-1 group (n = 143); Group 2: OAC-2 group (n = 155) treated for two weeks with OAC. The OAC-1 group was treated with triple therapy of omeprazole 20 mg, amoxicillin 1000 mg, and clarithromycin 500 mg bid for 1 week. OAC-2 group was treated likewise, but for two weeks. A 13C-urea breath test was used to monitor H. pylori after four to eight weeks following therapy.

Results: The eradication of infection was 55% and 68% in the OAC-1 and OAC-2 groups, respectively. Moreover, the eradication rates in the two groups were 63% and 75%, respectively. Compared with the OAC-1 group, the efficacy of treatment in the OAC-2 group is significantly higher (P < 0.05).

Conclusion: Two-week OAC regimen yields a higher eradication rate of H. pylori, which might be a practical regimen for the eradication of H. pylori.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Amoxicillin / administration & dosage
  • Anti-Bacterial Agents / administration & dosage
  • Clarithromycin / administration & dosage
  • Disease Eradication / methods
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / drug effects*
  • Humans
  • Intention to Treat Analysis / methods
  • Male
  • Metronidazole / administration & dosage
  • Middle Aged
  • Omeprazole / administration & dosage
  • Proton Pump Inhibitors / administration & dosage
  • Single-Blind Method

Substances

  • Anti-Bacterial Agents
  • Proton Pump Inhibitors
  • Metronidazole
  • Amoxicillin
  • Clarithromycin
  • Omeprazole